PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational. The innovative machinery from Cytiva can be used to fill various sterile medications into vials and syringes for small-to-mid scale client needs.
AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapies The latest purification technology will offer efficient processing time for plasmid DNA production BRISBANE, Australia, Feb. 10, 2023 /PRNewswire/ AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide a cGMP plasmid DNA CDMO service to the world using Cytiva's new process platform technology. Jon Ince (left), General Manager, Australia & New Zealand, Cytiva and Guillaume Herry (right), CEO of AcuraBio, at the contract signing ceremony AcuraBio expects to produce more plasmid DNA for its customers around the world using Cytiva's latest bacterial plasmid two-step purification protocol. The new protocol features single-use purification technology which delivers efficiency, high purity level outcome and s
AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapiesThe
Since its first description in 1979, Western blotting has become one of the most widely used methods in life science research. Whether you’re a beginner or an expert, this handbook from Cytiva is meant to guide and inspire. Here, Cytiva shares the latest expertise and technology to support your success from sample preparation to analysis. It describes the theoretical and practical aspects of the technique along with useful hints and tips. Over the past decade, improved detection methods
Located in Yangzhou of East China, Aurisco's new commercial manufacturing site is expected to produce 200 kilograms of oligonucleotides each year.Through the cooperation with Cytiva, Aurisco